RxDoctor Payments Data

Tracy McBride, NP

Family · Indianapolis, INNPI 1487612446

Payments from drug & device makers

$904in general payments, 2019–2025

Across 52 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$244
  • GSK$145
  • Novo Nordisk$91
  • Astellas Pharma US Inc$62
  • Otsuka America Pharmaceutical, Inc.$37
  • Abbott$35
  • plus $289 from 15 others

What the payments were for

  • Food & beverage$904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$904 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$49,517
Medicare patients
249
Services billed
746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol11$16,322
EliquisApixaban11$5,945
ArexvyRsvpref3 Antigen/As01e/Pf14$4,294
ShingrixVaricella-Zoster Ge/As01b/Pf14$3,169
Albuterol Sulfate HfaAlbuterol Sulfate36$1,021
TenivacTetanus-Diphtheria Toxoids/Pf16$946
Gabapentin29$831
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$565
Atorvastatin Calcium41$347
Cephalexin45$314
Alprazolam19$309
Losartan Potassium29$291
Valsartan19$261
Rosuvastatin Calcium15$227
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArexvy, Shingrix$145$7,46328 claims
PfizerEliquis$14$5,94511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,392 family providers in Indiana.

Other family in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →